Acute leukemia in the time of COVID-19
- 1 May 2020
- journal article
- letter
- Published by Elsevier BV in Leukemia Research
- Vol. 92, 106353
- https://doi.org/10.1016/j.leukres.2020.106353
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Coronaviruses and Immunosuppressed Patients: The Facts During the Third EpidemicLiver Transplantation, 2020
- Coronavirus Disease 2019: Coronaviruses and Blood SafetyTransfusion Medicine Reviews, 2020
- How do we plan hematopoietic cell transplant and cellular therapy with the looming COVID‐19 threat?British Journal of Haematology, 2020
- Cancer patients in SARS-CoV-2 infection: a nationwide analysis in ChinaThe Lancet Oncology, 2020
- Intensified Therapy of Acute Lymphoblastic Leukemia in Adults: Report of the Randomized GRAALL-2005 Clinical TrialJournal of Clinical Oncology, 2018
- Platelet Transfusion for Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline UpdateJournal of Clinical Oncology, 2018
- Enasidenib in mutant IDH2 relapsed or refractory acute myeloid leukemiaBlood, 2017
- Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panelBlood, 2017
- Minimal residual disease prior to allogeneic hematopoietic cell transplantation in acute myeloid leukemia: a meta-analysisHaematologica, 2017
- Revised International Prognostic Scoring System for Myelodysplastic SyndromesBlood, 2012